We are Happy to Lead Filtricine's Seed Funding Round
At Boutique Venture Partners, we are excited to partner with John, Xiyan, & Filtricine’s team. Filtricine, Inc. is developing a proprietary targeted medical food technology to help cancer patients manage their diseases.We were happy to lead this seed round with our collaborators at Berkeley Catalyst Fund with the continuing participation of True Ventures, SOSV, and Sand Hill Angels.In addition, I would like to thank everyone involved in getting this across the line:- S. Thad Connelly, Ryan Spitler, Ph.D., Craig Rochester, Matthew Wahlrab, Andrew Fisher- Drew Lanza, Adam D'Augelli, Po Bronson- John Chant, Xiyan Li, Grace Xiaolu Yang, Ph.D., Xin Wang, Michael Snyder, and all Filtricine's team.
Be informed & Subscribe
Enter your details below to be updated about our investment activities and newsletter.
Copyright © 2026 Boutique Venture Partners